investment

R&D

BIO-Europe Spring 2023, Basel, Switzerland – Part One

Travelling to Basel, Switzerland for Informa Connect / EBD Group’s BIO-Europe Spring, taking place at the Messe Congress Center between the 20th and 22nd March, pharmaphorum listened to par

News

Lilly doubles down on Irish plant, ups spend to near $1bn

Eli Lilly's close ties to Ireland’s pharma manufacturing sector have just got even stronger, after the US pharma announced plans to double its planned investment in a new

News

Illumina says Icahn’s board candidates “do not add value”

Illumina has bitten back against the attempt by billionaire activist investor Carl Icahn to introduce three members to its board, saying that they lack “experience in and

News

Carl Icahn planning proxy fight at Illumina; report

Billionaire activist investor and ‘corporate raider’ Carl Icahn is lining up a proxy battle at Illumina in the wake of its troubled $7.1 billion takeover of blood-based ca

News

Moderna picks Oxfordshire for UK facility

US biotech Moderna has chosen the location of its promised new R&D facility in the UK, selecting the Harwell Science Campus in Oxfordshire to site the unit.

News